clinical trial · NCT06658730
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
W.L.Gore & Associates·—·recruiting·n = 1,500
Vascular DiseaseDissectionDissection Aortic AneurysmDissection of AortaAneurysm ThoracicAneurysm DissectingTransection AortaIntramural HematomaEndovascular
brief summary
An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.
started
Jun 19, 2025
primary completion
Aug 1, 2038
completion
Aug 1, 2038
last updated
May 12, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol